Suppr超能文献

用与霍乱毒素B亚基偶联的变形链球菌抗原I/II进行鼻内免疫后,针对变形链球菌感染的唾液免疫球蛋白A保护性反应。

Protective salivary immunoglobulin A responses against Streptococcus mutans infection after intranasal immunization with S. mutans antigen I/II coupled to the B subunit of cholera toxin.

作者信息

Katz J, Harmon C C, Buckner G P, Richardson G J, Russell M W, Michalek S M

机构信息

Department of Microbiology, University of Alabama, Birmingham 35294.

出版信息

Infect Immun. 1993 May;61(5):1964-71. doi: 10.1128/iai.61.5.1964-1971.1993.

Abstract

The B subunit of cholera toxin (CTB) has been shown to augment mucosal responses to microbial virulence antigens, including those of Streptococcus mutans, which is the principal etiologic agent of dental caries. In the present study, the surface fibrillar protein antigen of S. mutans, antigen I/II (Ag I/II), was chemically coupled to CTB (Ag I/II-CTB), and the conjugate was examined for its effectiveness in inducing salivary immune responses protective against S. mutans infection. Weanling Fischer rats were given Ag I/II-CTB (50 micrograms) by the intranasal route and then orally infected with a virulent strain of S. mutans. Gnotobiotic or conventional rats were given two or three additional immunizations, respectively, at about 2-week intervals. One week after each immunization, individual serum, saliva, and fecal samples were collected and stored frozen until assayed for antibody activity to Ag I/II and cholera toxin (CT) by an enzyme-linked immunosorbent assay. The rats were sacrificed 1 week after the last immunization, when mandibles were also collected from individual rats for assessment of S. mutans levels in plaque and caries activity. Rats immunized only or both immunized and infected showed a salivary immunoglobulin A (IgA) anti-Ag I/II response which reached significantly (P < 0.05) higher levels than those seen in nonimmunized, infected controls. A salivary IgA anti-Ag I/II response was also seen in rats infected only with S. mutans. Essentially no salivary antibody activity to CT was detected. Some serum anti-Ag I/II and anti-CT responses were seen in immunized animals. Serum IgG anti-Ag I/II responses were seen in immunized, infected rats and also in infected-only rats, suggesting that the responses were a result of infection with S. mutans. The immunized and infected rats had significantly (P < 0.05) lower levels of S. mutans in plaque and lower caries activity than nonimmunized, infected rats. These results indicated that intranasal immunization of rats with Ag I/II-CTB induced a protective salivary immune response which was associated with a reduction in S. mutans colonization and S. mutans-induced dental caries.

摘要

霍乱毒素B亚基(CTB)已被证明可增强对微生物毒力抗原的黏膜反应,包括变形链球菌的抗原,变形链球菌是龋齿的主要病原体。在本研究中,将变形链球菌的表面纤维状蛋白抗原I/II(Ag I/II)与CTB化学偶联(Ag I/II-CTB),并检测该偶联物在诱导唾液免疫反应以抵御变形链球菌感染方面的有效性。给断奶的Fischer大鼠经鼻内途径给予Ag I/II-CTB(50微克),然后经口感染一株有毒力的变形链球菌。无菌或普通大鼠分别每隔约2周再进行2次或3次免疫接种。每次免疫接种1周后,收集个体血清、唾液和粪便样本并冷冻保存,直至通过酶联免疫吸附测定法检测其对Ag I/II和霍乱毒素(CT)的抗体活性。在最后一次免疫接种1周后处死大鼠,此时也从个体大鼠采集下颌骨,以评估菌斑中变形链球菌水平和龋齿活性。仅免疫或既免疫又感染的大鼠出现唾液免疫球蛋白A(IgA)抗Ag I/II反应,其水平显著(P<0.05)高于未免疫、感染的对照组。仅感染变形链球菌的大鼠也出现唾液IgA抗Ag I/II反应。基本上未检测到唾液对CT的抗体活性。在免疫动物中观察到一些血清抗Ag I/II和抗CT反应。在免疫、感染的大鼠以及仅感染的大鼠中均观察到血清IgG抗Ag I/II反应,这表明这些反应是变形链球菌感染的结果。与未免疫、感染的大鼠相比,免疫且感染的大鼠菌斑中变形链球菌水平显著(P<0.05)降低,龋齿活性也较低。这些结果表明,用Ag I/II-CTB对大鼠进行鼻内免疫可诱导保护性唾液免疫反应,这与变形链球菌定植减少和变形链球菌诱导的龋齿减少有关。

相似文献

3
Intranasal immunization against dental caries with a Streptococcus mutans-enriched fimbrial preparation.
Clin Diagn Lab Immunol. 1999 May;6(3):405-9. doi: 10.1128/CDLI.6.3.405-409.1999.
5
Remote glucosyltransferase-microparticle vaccine delivery induces protective immunity in the oral cavity.
Oral Microbiol Immunol. 2003 Aug;18(4):240-8. doi: 10.1034/j.1399-302x.2003.00074.x.

引用本文的文献

2
Viable and Heat-Killed Probiotic Strains Improve Oral Immunity by Elevating the IgA Concentration in the Oral Mucosa.
Curr Microbiol. 2021 Sep;78(9):3541-3549. doi: 10.1007/s00284-021-02569-8. Epub 2021 Aug 3.
3
The Multifaceted Nature of Streptococcal Antigen I/II Proteins in Colonization and Disease Pathogenesis.
Front Microbiol. 2020 Nov 25;11:602305. doi: 10.3389/fmicb.2020.602305. eCollection 2020.
4
Salivary IgA as a Useful Biomarker for Dental Caries in Down's Syndrome Patients: A Systematic Review and Meta-analysis.
Eur J Dent. 2020 Oct;14(4):665-671. doi: 10.1055/s-0040-1716443. Epub 2020 Sep 24.
6
Salivary IgA versus HIV and Dental Caries.
J Clin Diagn Res. 2016 Sep;10(9):ZC61-ZC64. doi: 10.7860/JCDR/2016/19394.8531. Epub 2016 Sep 1.
7
The Quest for an HIV-1 Vaccine Adjuvant: Bacterial Toxins as New Potential Platforms.
J Clin Cell Immunol. 2014 Jun;5(3). doi: 10.4172/2155-9899.1000225. Epub 2014 Jul 17.
9
Dental caries vaccine - a possible option?
J Clin Diagn Res. 2013 Jun;7(6):1250-3. doi: 10.7860/JCDR/2013/5246.3053. Epub 2013 Apr 11.
10
Immunomodulatory Polysaccharide from Chlorophytum borivilianum Roots.
Evid Based Complement Alternat Med. 2011;2011:598521. doi: 10.1093/ecam/neq012. Epub 2011 Jan 9.

本文引用的文献

3
Distribution of cross-reactive antigens A and B in Streptococcus mutans and other oral streptococci.
J Gen Microbiol. 1980 Jun;118(2):383-8. doi: 10.1099/00221287-118-2-383.
4
Mucosal immunology.
Immunology. 1980 Oct;41(2):249-70.
8
Development of immunological capacity under germfree and conventional conditions.
Ann N Y Acad Sci. 1983 Jun 30;409:96-113. doi: 10.1111/j.1749-6632.1983.tb26862.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验